Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62,901 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome.
Park SS, Jeon YW, Min GJ, Park S, Yahng SA, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Lee S, Kim HJ, Min CK, Cho SG, Lee JW, Kim YJ. Park SS, et al. Among authors: park s. Biol Blood Marrow Transplant. 2019 Jan;25(1):63-72. doi: 10.1016/j.bbmt.2018.08.004. Epub 2018 Aug 10. Biol Blood Marrow Transplant. 2019. PMID: 30103018 Free article. Clinical Trial.
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party.
Jung SH, Lee SR, Yang DH, Lee S, Yoon JH, Lee H, Bang SM, Koh Y, Park S, Kim DS, Yhim HY, Kim SH, Lee JH, Sohn SK, Song IC, Lee HG, Cheong JW, Choi Y, Shin HJ. Jung SH, et al. Among authors: park s. Ann Hematol. 2019 Jan;98(1):151-158. doi: 10.1007/s00277-018-3495-2. Epub 2018 Sep 26. Ann Hematol. 2019. PMID: 30259121 Clinical Trial.
Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Jeon YW, Yoon S, Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Lee JW, Cho SG. Jeon YW, et al. Among authors: park ss, park s. Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):345-355.e7. doi: 10.1016/j.clml.2019.03.023. Epub 2019 Mar 30. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31014757 Free article.
Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma.
Jeon YW, Yoon S, Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Lee JW, Cho SG. Jeon YW, et al. Among authors: park ss, park s. Ann Hematol. 2019 Jul;98(7):1743-1753. doi: 10.1007/s00277-019-03714-x. Epub 2019 May 14. Ann Hematol. 2019. PMID: 31089793 Free PMC article.
Excellent outcomes of hematopoietic stem cell transplantation with total nodal irradiation and antithymocyte globulin conditioning in severe aplastic anemia with advanced age and/or severe comorbidity.
Park SS, Min GJ, Park S, Lee SE, Yoon JH, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Lee JW. Park SS, et al. Among authors: park s. Bone Marrow Transplant. 2020 Jul;55(7):1447-1450. doi: 10.1038/s41409-019-0696-9. Epub 2019 Sep 24. Bone Marrow Transplant. 2020. PMID: 31551520 No abstract available.
62,901 results
You have reached the last available page of results. Please see the User Guide for more information.